Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar 16:10:1160672.
doi: 10.3389/fmed.2023.1160672. eCollection 2023.

Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study

Anna Pira  1 , Chiara Moltrasio  2 , Damiano Abeni  3 , Alberto Corrà  4 , Angelo Valerio Marzano  2   5 , Marzia Caproni  6 , Giovanni Di Zenzo  1
Affiliations
Comment

Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study

Anna Pira et al. Front Med (Lausanne). .
No abstract available

Keywords: COVID-19; SARS-CoV-2; autoimmune bullous disease; bullous pemphigoid; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Kasperkiewicz M, Tukaj S. Commentary: Bullous pemphigoid associated with COVID-19 vaccines: an Italian multicenter study. Front Med. (2022) 9:1096867. 10.3389/fmed.2022.1096867 - DOI - PMC - PubMed
    1. Maronese CA, Caproni M, Moltrasio C, Genovese G, Vezzoli P, Sena P, et al. . Bullous pemphigoid associated with COVID-19 vaccines: an Italian multicentre study. Front Med (Lausanne). (2022) 9:841506. 10.3389/fmed.2022.841506 - DOI - PMC - PubMed
    1. Birabaharan M, Kaelber DC, Orme CM, Paravar T, Karris MY. Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination. Br J Dermatol. (2022) 187:271–3. 10.1111/bjd.21240 - DOI - PMC - PubMed
    1. Kasperkiewicz M, Bednarek M, Tukaj S. Case report: circulating AntiSARS-CoV-2 antibodies do not cross-react with pemphigus or pemphigoid autoantigens. Front Med. (2021) 8:807711. 10.3389/fmed.2021.807711 - DOI - PMC - PubMed
    1. Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, et al. . New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. (2022) 165:386–401. 10.1111/imm.13443 - DOI - PubMed